Successful Management of Steroid-Resistant Cutaneous Acute Graft-Versus-Host Disease, Toxic Epidermal Necrolysis-Like, With Ruxolitinib. Mediterr J Hematol Infect Dis 2025, 17 (1), e2025020. https://doi.org/10.4084/MJHID.2025.020.